Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -16.69%348.13M | 11.56%759.46M | 10.33%417.89M | -8.13%680.74M | -33.00%378.74M | -16.88%740.95M | 32.78%565.27M | 49.04%891.41M | 58.72%425.73M | 82.07%598.12M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 4.92%-9.21M | -38.61%-21.79M | -128.25%-9.69M | 22.80%-15.72M | 72.78%-4.24M | 48.64%-20.37M | -23.36%-15.59M | -44.11%-39.65M | -23.98%-12.64M | -42.33%-27.52M |
| Interest expense - adjustment | -31.76%1.1M | -46.06%3.17M | -53.14%1.61M | 46.19%5.87M | 80.01%3.44M | 15.15%4.01M | 24.01%1.91M | 132.71%3.49M | 106.29%1.54M | 12.29%1.5M |
| Dividend (income)- adjustment | ---- | ---9.45M | 23.78%-4.27M | ---- | ---5.6M | ---- | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---934K | --26K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | 48.97%96.25M | 60.80%74.15M | 2.03%64.61M | -62.93%46.11M | 21.37%63.33M | 121.56%124.39M | 52.10%52.18M | 84.47%56.14M | 93.67%34.3M | 26.19%30.43M |
| -Impairment of trade receivables (reversal) | 36.67%92.91M | 92.21%75.67M | 5.96%67.98M | -68.35%39.37M | 50.39%64.15M | 121.56%124.39M | 18.91%42.66M | 84.47%56.14M | 105.35%35.87M | 87.33%30.43M |
| -Other impairments and provisions | 199.32%3.34M | -122.60%-1.52M | -307.63%-3.37M | --6.74M | -108.68%-826K | ---- | 706.63%9.52M | ---- | -743.03%-1.57M | ---- |
| Revaluation surplus: | -50.93%3.58M | 60.53%41.51M | -54.66%7.3M | 122.24%25.86M | 135.81%16.09M | -89.82%-116.26M | -74.67%-44.93M | -710.36%-61.25M | -4,223.19%-25.72M | -188.91%-7.56M |
| -Fair value of investment properties (increase) | 109.53%410K | 289.46%13.73M | 75.60%-4.3M | -491.59%-7.25M | -9,135.90%-17.62M | 81.89%-1.23M | 195.45%195K | -512.04%-6.76M | 111.09%66K | 57.76%-1.11M |
| -Other fair value changes | -72.66%3.17M | -16.09%27.78M | -65.60%11.6M | 128.78%33.1M | 174.71%33.71M | -111.14%-115.04M | -74.98%-45.13M | -744.32%-54.48M | ---25.79M | ---6.45M |
| Asset sale loss (gain): | -62.35%1.3M | 2,768.18%4.11M | 6,660.78%3.45M | -190.59%-154K | -68.90%51K | 495.35%170K | 707.41%164K | -121.94%-43K | -106.91%-27K | 228.10%196K |
| -Loss (gain) from sale of subsidiary company | 300.00%1.39M | --146K | --348K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -683.33%-94K | 859.09%1.17M | -117.14%-12K | -190.59%-154K | -57.32%70K | 495.35%170K | 707.41%164K | -121.94%-43K | -106.91%-27K | 833.33%196K |
| -Loss (gain) from selling other assets | ---- | --2.79M | 16,478.95%3.11M | ---- | ---19K | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | -25.31%36.71M | -24.00%85.01M | 18.11%49.15M | 19.89%111.87M | -8.19%41.61M | 27.06%93.31M | 50.56%45.32M | 9.03%73.44M | 32.29%30.1M | 230.83%67.36M |
| -Amortization of intangible assets | -20.59%18.33M | -23.17%42.16M | -12.95%23.08M | 8.77%54.88M | 0.74%26.52M | 24.68%50.45M | 53.05%26.33M | 14.58%40.46M | 85.38%17.2M | 702.59%35.31M |
| Exchange Loss (gain) | -74.65%1.04M | -3.00%2.94M | 2,717.83%4.11M | -71.98%3.03M | -101.68%-157K | -38.56%10.82M | 2.00%9.36M | -78.51%17.61M | 219.27%9.18M | 865.30%81.94M |
| Special items | ---- | ---- | ---- | ---- | ---- | 443.46%33.04M | ---- | 254.46%6.08M | ---- | --1.72M |
| Operating profit before the change of operating capital | -10.52%477.96M | 9.51%939.12M | 8.29%534.15M | -1.43%857.6M | -19.62%493.27M | -8.15%870.06M | 32.70%613.69M | 26.94%947.22M | 57.66%462.46M | 118.23%746.19M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 475.00%300K | 901.46%1.65M | 91.29%-80K | -136.27%-206K | -1,076.60%-918K | 131.93%568K | 107.54%94K | ---1.78M | ---1.25M | ---- |
| Accounts receivable (increase)decrease | -108.61%-516.93M | 18.62%-350.63M | 47.76%-247.8M | 60.79%-430.84M | 7.75%-474.39M | -233.26%-1.1B | -105.90%-514.25M | -162.75%-329.73M | -86.66%-249.76M | 30.64%-125.49M |
| Accounts payable increase (decrease) | 1,287.62%184.13M | -39.69%143.41M | -973.46%-15.5M | -49.76%237.8M | -99.46%1.78M | -2.52%473.3M | 17.21%328.65M | 61.35%485.56M | 286.96%280.38M | 3.87%300.94M |
| prepayments (increase)decrease | -230.09%-54.7M | -62.30%95.34M | 507.70%42.05M | 124.80%252.89M | 107.06%6.92M | -350.67%-1.02B | -271.86%-97.99M | -79.23%-226.24M | -172.06%-26.35M | -676.65%-126.23M |
| Financial assets at fair value (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---24.54M | ---19.25M | ---- | ---- | ---- |
| Special items for working capital changes | -86.60%-204.15M | -90.64%16.2M | -157.84%-109.4M | 543.61%173.06M | 1,663.24%189.15M | -84.37%26.89M | -113.26%-12.1M | 394.04%172.09M | 105.17%91.27M | -72.45%34.83M |
| Cash from business operations | -155.74%-113.39M | -22.49%845.09M | -5.74%203.41M | 241.20%1.09B | -27.78%215.8M | -173.74%-772.19M | -46.33%298.83M | 26.12%1.05B | 77.86%556.76M | 48.02%830.24M |
| Other taxs | -14.40%-116.48M | 9.55%-160.28M | 12.01%-101.82M | 28.41%-177.21M | 29.61%-115.72M | -17.81%-247.53M | -25.04%-164.39M | -73.45%-210.11M | -80.12%-131.47M | -131.96%-121.14M |
| Net cash from operations | -326.26%-229.87M | -25.00%684.81M | 1.51%101.59M | 189.54%913.1M | -25.55%100.08M | -221.83%-1.02B | -68.39%134.44M | 18.04%837.01M | 77.17%425.29M | 39.40%709.1M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -4.92%9.21M | 38.61%21.79M | 128.25%9.69M | -26.41%15.72M | -74.42%4.24M | -46.12%21.37M | 24.30%16.59M | 44.11%39.65M | 30.93%13.35M | 42.33%27.52M |
| Dividend received - investment | ---- | --9.45M | -23.78%4.27M | ---- | --5.6M | ---- | ---- | ---- | ---- | ---- |
| Restricted cash (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%43M |
| Sale of fixed assets | 150.00%45K | -32.88%6.13M | -99.26%18K | 193.10%9.13M | 42.26%2.43M | 1,151.41%3.12M | 101.65%1.71M | -66.12%249K | --846K | 223.79%735K |
| Purchase of fixed assets | -12.90%-11.29M | 32.19%-26.4M | 43.31%-10M | -11.56%-38.93M | -31.56%-17.63M | 4.73%-34.9M | 58.92%-13.4M | -17.12%-36.63M | -585.17%-32.63M | -0.18%-31.28M |
| Purchase of intangible assets | 16.25%-11.09M | -76.96%-21.22M | -250.73%-13.25M | -3.92%-11.99M | 3.55%-3.78M | 49.78%-11.54M | 58.54%-3.92M | ---22.98M | -236.16%-9.45M | ---- |
| Sale of subsidiaries | -248.09%-3.19M | ---1.14M | ---917K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | 100.51%2.4M | 103.53%2.4M | 51.95%-471.14M | 76.55%-67.81M | -3,152.24%-980.49M | -1,014.39%-289.22M | 89.13%-30.15M |
| Recovery of cash from investments | -17.71%85.2M | 80.38%272.38M | 264.70%103.54M | -97.07%151M | -98.99%28.39M | 51.81%5.15B | 302.74%2.8B | 940.52%3.39B | 674,743.69%695.09M | 25,866.93%325.89M |
| Cash on investment | -20.03%-85.2M | -71,780.46%-220.67M | -157.96%-70.98M | 99.99%-307K | 104.45%122.47M | -70.54%-5.63B | -236.04%-2.75B | -937.21%-3.3B | ---818.5M | ---318.5M |
| Other items in the investment business | ---1M | 75.10%-1.54M | ---- | -37.35%-6.19M | ---- | -7.34%-4.5M | ---- | 86.02%-4.2M | ---- | ---30M |
| Net cash from investment operations | -177.41%-17.32M | -67.91%38.77M | -84.48%22.37M | 112.28%120.83M | 904.07%144.11M | -7.26%-983.61M | 95.93%-17.92M | -7,069.07%-917M | -2,477.02%-440.51M | 95.98%-12.79M |
| Net cash before financing | -299.40%-247.19M | -30.02%723.58M | -49.24%123.96M | 151.61%1.03B | 109.59%244.2M | -2,404.53%-2B | 865.47%116.51M | -111.49%-79.99M | -105.89%-15.22M | 265.50%696.31M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 145.85%36.88M | -28.56%34.5M | -57.69%15M | 4.69%48.29M | 50.51%35.45M | --46.13M | --23.56M | ---- | ---- | ---- |
| Refund | -18.30%-25.66M | 50.28%-46.73M | 48.16%-21.69M | -201.85%-93.98M | -486.67%-41.84M | -401.90%-31.13M | ---7.13M | -106.56%-6.2M | ---- | 67.64%-3M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -24.63%1.09B | ---- | 2,457.65%1.44B |
| Interest paid - financing | 35.17%-787K | 37.20%-3.17M | 51.61%-1.21M | -113.83%-5.04M | -129.76%-2.51M | -53.65%-2.36M | -76.13%-1.09M | -2.40%-1.53M | 17.00%-620K | -12.29%-1.5M |
| Dividends paid - financing | 22.13%-132.82M | -101.17%-402.31M | -1,209.22%-170.57M | 51.78%-199.98M | 94.57%-13.03M | -139.37%-414.76M | -64.56%-239.92M | -69.72%-173.28M | -60.52%-145.8M | -60.65%-102.09M |
| Absorb investment income | ---- | -86.48%6.39M | 36.99%1M | 1,969.86%47.26M | -32.41%730K | -96.78%2.28M | -55.92%1.08M | 961.82%70.94M | -14.16%2.45M | 91.65%6.68M |
| Issuance expenses and redemption of securities expenses | ---- | -235.85%-20.63M | ---20.18M | 79.43%-6.14M | ---- | -94.45%-29.86M | ---17.32M | -20.12%-15.36M | ---- | ---12.78M |
| Other items of the financing business | ---30K | ---- | ---- | 70.12%-1.4M | ---- | 87.43%-4.69M | ---- | 13.26%-37.3M | ---- | 28.33%-43M |
| Net cash from financing operations | 37.35%-128.31M | -98.55%-444.3M | -615.56%-204.8M | 50.10%-223.77M | 88.46%-28.62M | -149.38%-448.46M | -62.91%-248.05M | -28.63%908.09M | -111.87%-152.26M | 1,633.98%1.27B |
| Effect of rate | 74.65%-1.04M | 3.00%-2.94M | -2,717.83%-4.11M | -373.06%-3.03M | -78.78%157K | 108.13%1.11M | 110.39%740K | 83.29%-13.65M | -192.57%-7.12M | -612.02%-81.67M |
| Net Cash | -364.49%-375.49M | -65.53%279.28M | -137.50%-80.84M | 133.04%810.17M | 263.89%215.57M | -396.07%-2.45B | 21.46%-131.54M | -57.93%828.11M | -110.87%-167.49M | 1,730.10%1.97B |
| Begining period cash | 11.80%2.62B | 52.60%2.34B | 52.60%2.34B | -61.50%1.53B | -61.50%1.53B | 25.69%3.99B | 25.69%3.99B | 147.00%3.17B | 147.00%3.17B | 10.65%1.28B |
| Cash at the end | -0.68%2.24B | 11.80%2.62B | 28.94%2.26B | 52.60%2.34B | -54.59%1.75B | -61.50%1.53B | 28.65%3.85B | 25.69%3.99B | 5.76%3B | 147.00%3.17B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.17B |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.17B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Pak Chun Certified Public Accountants Limited | -- | Pak Chun Certified Public Accountants Limited | -- | Pak Chun Certified Public Accountants Limited | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.